Senolytic Drugs Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027 Segmented By Type (FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib & Quercetin, Others), By Application (Longevity, Senescence Inhibition, Cardiovascular Diseases, Neural Degenerative Diseases, Others), By Distribution Channel (Retail Pharmacies,
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationSenolytic Drugs Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027 Segmented By Type (FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib & Quercetin, Others), By Application (Longevity, Senescence Inhibition, Cardiovascular Diseases, Neural Degenerative Diseases, Others), By Distribution Channel (Retail Pharmacies,
Global senolytic drugs market is anticipated to grow with an impressive CAGR value in the mentioned forecast years 2023-2027 on the account of increasing demand for the anti-aging pharmaceuticals and therapeutics. Increase in the advancement of the pharmaceutical products that have the ability to increase healthy lifespan is further driving the growth of the global senolytic drugs market in the upcoming five years.
Senolytic drugs are the pharmaceutical products or a class of drugs that is targeted over the senescent cells and destroys them with their effects. Senescence is a biological process in which cells age but do not divide to create daughter cells and also don’t die. In sometime these cells start to accumulate and form a tumor like structure inside the human body. Senescence is not only responsible for a human body to grow old but may also cause development of cancer and other diseases. Skin wrinkling, weaker eyesight, weaker hearing capacity are some of the major examples of senescence that causes old age in humans.
Increasing Demand For Anti-Aging Products Drive Market Growth
Increasing demand for the anti-aging drugs and pharmaceutical products that kills the senescent cells to increase healthy lifespan of the human beings, is driving the growth of the global senolytic drugs market in the upcoming five years. Also, rising geriatric population in the world is also supporting the growth of the global senolytic drugs market in the next five years.
According to the United Nations Department of Economic and Social Affairs, Population Division, the number of people aged 65 years or above was 702.9 million in 2019. This number is expected to grow by 120% and reach 1548.9 million by 2050.
Increasing Chronic Diseases Drive Market Growth
Senescent cells are linked to the increasing cases of age-related diseases. Increasing instances of diseases like cataract, glaucoma, neurodegenerative diseases (Alzheimer and Parkinson), cardiovascular diseases (CVD, atherosclerosis, and hypertension), idiopathic pulmonary fibrosis (IPF), diabetes type II, sarcopenia, osteoarthritis, osteoporosis, chronic obstructive pulmonary disease (COPD), and certain types of tumors, are majorly responsible for the growing demand for senolytic drugs to decrease the risks of such chronic diseases, thus substantiate the growth of the global senolytic drugs market in the future five years.
According to Center for Disease Control and Prevention, Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. One person dies every 36 seconds in the United States from cardiovascular disease. About 659,000 people in the United States die from heart disease each year—that’s 1 in every 4 deaths.
Click here to download the sample
Market Segmentation
The global senolytic drugs market segmentation is based on type, application, distribution channel, regional distribution, and competitive landscape. Based on type, the market is fragmented into FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib & Quercetin, and others. Market segmentation based on application, bifurcates into longevity, senescence inhibition, cardiovascular diseases, neural degenerative diseases, and others.
On the basis of distribution channel, the market is sub-segmented into retail pharmacies, hospital pharmacies, and online pharmacies.
Company Profile
AgeX Therapeutics, Inc., Cleara Biotech, Eternans Ltd., FoxBio Inc., Numeric Biotech, T.A. Sciences, Inc., Recursion Pharmaceuticals, Inc, are enlisted in a partial list of major market players of the global senolytic drugs market. The existing market players are highly invested in research and product development along with viable service provisions for the consumers. New market entrants may follow similar strategies along with merger and acquisition methods for future brand establishment.
Attribute | Details |
Base Year | 2021 |
Historical Data | 2017 – 2020 |
Estimated Year | 2022 |
Forecast Period | 2023 – 2027 |
Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered |
|
Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
Country scope | United States, Mexico, Canada, China, India, Japan, South Korea, Australia, Germany, France, United Kingdom, Spain, Italy, South Africa, UAE, Saudi Arabia, Brazil, Argentina, Colombia |
Key companies profiled | AgeX Therapeutics, Inc., Cleara Biotech, Eternans Ltd., FoxBio Inc., Numeric Biotech, T.A. Sciences, Inc., Recursion Pharmaceuticals, Inc |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy